{"id":27922,"date":"2021-11-13T19:02:30","date_gmt":"2021-11-13T18:02:30","guid":{"rendered":"https:\/\/www.transgene.com\/?p=27922"},"modified":"2022-06-07T17:22:38","modified_gmt":"2022-06-07T15:22:38","slug":"annonce","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/annonce\/","title":{"rendered":"annonce"},"content":{"rendered":"\n\n\n<div class=\"eplus-SbjXLy wp-block-columns eplus-wrapper is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"eplus-kLEoHv wp-block-column eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\">\n<div id=\"annonceHome\" class=\"wp-block-columns alignfull eplus-1ruALO\">\n<div id=\"therapeuticvaccines\" class=\"wp-block-column eplus-17Ffl8 bandeau\">\n<div>\n<h1 style=\"text-align: center; color: #ffffff;\">Premiers r\u00e9sultats positifs <br>des essais de Phase I<\/h1>\n<div class=\"OAM-arrow\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-28928 size-full aligncenter\" src=\"https:\/\/www.transgene.com\/wp-content\/uploads\/arrowDown.gif\" alt=\"\" width=\"250\" height=\"200\"><\/div>\n<\/div>\n<div id=\"annonce-lien\">\n<p style=\"text-align: center; color: white;\"><a href=\"https:\/\/www.transgene.com\/CP.php?f=29308&amp;link=20211122-results-myvac-FR.pdf\" target=\"_blank\" rel=\"noopener\">Communiqu\u00e9 [PDF]<\/a><\/p>\n<p style=\"text-align: center; color: white;\"><a href=\"https:\/\/player.vimeo.com\/video\/648574054\" target=\"_blank\" rel=\"noopener\">Interview de l\u2019\u00e9quipe et du Professeur Ottensmeier sur les r\u00e9sultats <\/a><\/p>\n<p style=\"text-align: center; color: white;\"><a href=\"https:\/\/channel.royalcast.com\/landingpage\/transgene\/20211123_1\/\" target=\"_blank\" rel=\"noopener\" data-wplink-url-error=\"true\">\u00c9coutez le webcast <br>en compagnie du Professeur Delord (en fran\u00e7ais)<\/a><\/p>\n<p style=\"text-align: center; color: white;\"><a href=\"https:\/\/channel.royalcast.com\/landingpage\/transgene\/20211123_2\/\" target=\"_blank\" rel=\"noopener\" data-wplink-url-error=\"true\">\u00c9coutez le webcast <br>en compagnie du Professeur Ottensmeier (en anglais)<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"eplus-LGzveY cgProduct wp-block-columns eplus-wrapper is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"eplus-eypt3I wp-block-column eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<h2>Un patient, un cancer, un vaccin<\/h2>\n<h3 class=\"cgDeg2\"><b>Avec TG4050, Transgene d\u00e9veloppe une immunoth\u00e9rapie individualis\u00e9e issue de technologies avanc\u00e9es d\u2019ing\u00e9nierie g\u00e9n\u00e9tique et d\u2019intelligence artificielle (IA). <br><\/b>Le traitement repose sur un vecteur viral optimis\u00e9, le&nbsp;MVA.<\/h3>\n\n\n\n<p>&nbsp;<\/p>\n<p><a class=\"btnVideo cgProductVideo\" title=\"\" href=\"https:\/\/vimeo.com\/481155014?width=640&amp;height=480\" rel=\"wp-video-lightbox\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone  wp-image-27522\" src=\"..\/..\/..\/wp-content\/uploads\/btn-video.svg\" alt=\"\" width=\"101\" height=\"63\"> &nbsp;<em>myvac<\/em>\u00ae video<\/a><\/p>\n<\/div>\n\n\n\n<div class=\"eplus-VVuil8 wp-block-column eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<p>Chaque traitement est con\u00e7u et fabriqu\u00e9 par Transgene, sur mesure, pour chaque patient, en visant les cibles tumorales les plus pertinentes (n\u00e9oantig\u00e8nes propres \u00e0 chaque cancer) s\u00e9lectionn\u00e9es par l\u2019IA de NEC.<\/p>\n<p>Un fois inject\u00e9 au malade, ce vaccin th\u00e9rapeutique va stimuler les d\u00e9fenses immunitaires du patient pour permettre une destruction cibl\u00e9e des cellules canc\u00e9reuses.<\/p>\n<p><b>Pour mener \u00e0 bien ce projet, Transgene s\u2019appuie sur une expertise unique, un r\u00e9seau de partenaires prestigieux et reconnus \u00e0 chaque \u00e9tape de la conception du produit et des capacit\u00e9s manufacturi\u00e8res int\u00e9gr\u00e9es. <\/b><\/p>\n<figure class=\"wp-block-image size-full eplus-YPnM8s\"><img decoding=\"async\" class=\"wp-image-27869\" src=\"https:\/\/www.transgene.com\/wp-content\/uploads\/process.svg\" alt=\"\" \/><\/figure>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Premiers r\u00e9sultats positifs des essais de Phase I Communiqu\u00e9 [PDF] Interview de l\u2019\u00e9quipe et du Professeur Ottensmeier sur les r\u00e9sultats \u00c9coutez le webcast en compagnie du Professeur Delord (en fran\u00e7ais) \u00c9coutez le webcast en compagnie du Professeur Ottensmeier (en anglais) Un patient, un cancer, un vaccin Avec TG4050, Transgene d\u00e9veloppe une immunoth\u00e9rapie individualis\u00e9e issue de&hellip; <a class=\"more-link\" href=\"https:\/\/www.transgene.com\/fr\/annonce\/\">Poursuivre la lecture <span class=\"screen-reader-text\">annonce<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[110],"tags":[],"class_list":["post-27922","post","type-post","status-publish","format-standard","hentry","category-outils-produits","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"Premiers r\u00e9sultats positifs des essais de Phase I Communiqu\u00e9 [PDF] Interview de l\u2019\u00e9quipe et du Professeur Ottensmeier sur les r\u00e9sultats \u00c9coutez le webcast en compagnie du Professeur Delord (en fran\u00e7ais) \u00c9coutez le webcast en compagnie du Professeur Ottensmeier (en anglais) Un patient, un cancer, un vaccin Avec TG4050, Transgene d\u00e9veloppe une immunoth\u00e9rapie individualis\u00e9e issue de&hellip;\u2026","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/27922","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=27922"}],"version-history":[{"count":0,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/27922\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=27922"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=27922"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=27922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}